These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 4309162)
21. [Treatment with secondary antitubercular agents]. Ovreberg K Tidsskr Nor Laegeforen; 1968 May; 88(9):741-9. PubMed ID: 4298856 [No Abstract] [Full Text] [Related]
22. In vitro and in vivo studies to assess the suitability of anti-tuberculous drugs for use in intermittent chemotherapy regimens. Dickinson JM Bull Int Union Tuberc; 1968 Dec; 41():309-15. PubMed ID: 4179554 [No Abstract] [Full Text] [Related]
23. Duration of application and change of a regimen with secondary drugs. Oka S; Takase Y; Kato S Sci Rep Res Inst Tohoku Univ Med; 1968 Oct; 15(1):46-9. PubMed ID: 4308926 [No Abstract] [Full Text] [Related]
28. Chemotherapy of tuberculosis. Lester W Clin Notes Respir Dis; 1970; 9(2):3-13. PubMed ID: 4319281 [No Abstract] [Full Text] [Related]
29. [Internal medicine treatment of pulmonary tuberculosis]. Schaich W Med Klin; 1970 Sep; 65(36):1553-8. PubMed ID: 4995072 [No Abstract] [Full Text] [Related]
30. The problem of the chronic excretor of tubercle bacilli. Stýblo K; Kubík A; Langerová M; Matusková E; Morávková K Scand J Respir Dis; 1968; 49(3):236-48. PubMed ID: 4309247 [No Abstract] [Full Text] [Related]
31. [Polychemotherapy of patients with chronic destructive forms of pulmonary tuberculosis in interregional tuberculosis hospitals]. Shimko NP; Maĭovetskaia NS; Severina MV; Alimova LV Probl Tuberk; 1989; (3):60-4. PubMed ID: 2726714 [No Abstract] [Full Text] [Related]
32. Intermittent chemotherapy or improvement of initial treatment in tuberculosis. Oka S Sci Rep Res Inst Tohoku Univ Med; 1971 Jul; 18(1):1-6. PubMed ID: 4949334 [No Abstract] [Full Text] [Related]
33. [New combinations of drugs for the treatment of drug-resistant tuberculosis]. Schmelev NA Bull Int Union Tuberc; 1968 Dec; 41():192-3. PubMed ID: 5710248 [No Abstract] [Full Text] [Related]
34. [Effect of the addition of the 3rd agent on the combined therapy with ethionamide and kanamycin in tuberculosis in the mice]. Matsumiya T; Freerksen E; Rosenfeld M Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):30-4. PubMed ID: 4991617 [No Abstract] [Full Text] [Related]
35. General considerations in intermittent drug therapy of pulmonary tuberculosis. Fox W Postgrad Med J; 1971 Nov; 47(553):729-36. PubMed ID: 4110537 [TBL] [Abstract][Full Text] [Related]
36. [Ethambutol combined with streptomycin and isoniazid for the original treatment cases of pulmonary tuberculosis]. Donomae I; Fujita S; Gomi J; Hayashi N; Hibino S Kekkaku; 1970 Feb; 45(2):55-60. PubMed ID: 5439133 [No Abstract] [Full Text] [Related]
37. [Comparison of combination therapy of Capreomycin, ethionamide and cycloserin with that of kanamycin, ethionamide and cycloserin for the retreatment of pulmonary tuberculosis]. Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K Saishin Igaku; 1970 Jul; 25(7):1546-55. PubMed ID: 5451178 [No Abstract] [Full Text] [Related]
39. MODERN DRUG TREATMENT OF MYCOBACTERIAL DISEASES. WOLINSKY E Med Clin North Am; 1963 Sep; 47():1271-83. PubMed ID: 14062093 [No Abstract] [Full Text] [Related]
40. Ethambutol in the treatment of 26 patients with chronic active pulmonary tuberculosis. Jesiotr M Tubercle; 1969 Mar; 50():Suppl:54-5. PubMed ID: 4319133 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]